Final hours! Save up to 50% OFF InvestingProCLAIM SALE

Value Investors: These 3 Stocks Are Ridiculously Cheap

Published 2019-05-09, 09:36 a/m
Value Investors: These 3 Stocks Are Ridiculously Cheap
Value Investors: These 3 Stocks Are Ridiculously Cheap

One thing value investors like to do during bull markets is close their wallets and avoid buying stocks because most names are deemed to be “too expensive.”

I prefer a different attitude, however. There’s little doubt that most stocks are more expensive when the rest of the market is doing well. But there are still pockets of value everywhere. You just have to look a little harder.

Let’s take a look at three of the cheapest stocks in Canada today. You won’t believe how cheap some of these names are.

CI Financial I’ve been bearish on the mutual fund industry for a little while now, even going as far as saying one company in the industry is an immediate sell and perhaps even a short candidate.

But I cannot deny how cheap CI Financial Corp (TSX:CIX) shares are today, which makes me bullish for the future, even if the company operates in a sector I think is poised for a long-term decline.

CI earned $2.39 per share in 2018 versus a current share price of $19.25, putting shares at a mere 8.1 times trailing earnings. Analysts are still relatively bullish on 2019’s results too, with earnings expectations coming in at $2.42 per share.

The stock is even cheaper from a price-to-free cash flow perspective. Free cash flow was $2.52 per share in 2018 with an average share count of 259.3 million shares. CI is in the middle of an aggressive stock repurchase plan; the company’s shares outstanding fell to just 243.3 million by the end of the year. It repurchased some 28.5 million shares in 2018 alone, with plans to gobble up more in 2019.

If free cash flow stays the same and the company repurchases another 28.5 million shares this year, free cash flow per share would be over $3 per share in 2020. The share buyback continued through the first quarter, with an additional $60.8 million spent on share repurchases.

The company is also expanding into other segments of the financial industry, including buying an ETF operator and a robo-advisor. These diversification moves should work out well in the long term.

Versabank I’ve long argued that value investors looking to pay bargain prices for growth stocks should check out Canada’s smaller banks. Most investors don’t look past the five biggest Canadian banks, and are therefore missing some true bargains.

VersaBank (TSX:VB) is a rapidly growing online-only bank that has expanded into other areas of the financial sector like commercial lending and receivables lending for e-commerce companies. The company uses technology much more than the average bank, using it to help make better lending decisions. It seems to be working; VersaBank has just 0.02% of its loans put aside for losses. Its competitors average around 0.3%.

Investors are getting this superior performance at a ridiculously low valuation. VersaBank shares trade at just 9.1 times earnings and at a 30% discount to book value. The company has also nearly tripled its earnings per share since 2014. You won’t find that combination of growth and value in a Big Five Canadian bank.

Bausch Health You might remember Bausch Health Companies Inc. (TSX:BHC)(NYSE:BHC) better by its previous name, Valeant. The company skyrocketed to the top of the TSX before crashing in spectacular fashion. But something interesting has happened since the 2017 bottom. Shares are quietly up some 400%, recently hitting $35 each on the back of good quarterly results.

Bausch’s main problem was its balance sheet, which investors doubted was strong enough to weather the storm of weaker results and an accounting scandal. But management has done a nice job improving the liabilities side without selling too many assets. Net debt has fallen from a peak of more than US$30 billion to US$24.5 billion today.

Recent results have also been solid, with the company experiencing a nice uptick from its international division, which saw sales increase 8% versus the same quarter last year. Eye care products have been strong, leading to 5% organic growth for the quarter. This was the best quarterly organic sales growth since 2015.

Bausch is a free cash flow monster, which doesn’t really reflect in its earnings per share numbers. It generated US$1.5 billion in cash from operations in 2018, while capital expenditures were minimal. The company’s market cap is US$9.3 billion, putting shares at just 6.2 times cash flow. Even after the big move, shares are still cheap.

Fool contributor Nelson Smith owns shares of CI FINANCIAL CORP. The Motley Fool owns shares of CI FINANCIAL CORP and has the following options: short July 2019 $19 calls on CI FINANCIAL CORP.

The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool Canada’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Motley Fool Canada 2019

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.